Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
CFGN= dilution! he keeps undercut ask!
Good thing?? $30,204.330 million notes!
have anyone here looked into the recent financial filings?
truly hope so for longs! just mad on how they brought it down here on good news!!
scammer keep showing fake 10 million bid to suck more victims!
lie!! no 8-k out! this will below 0.01 now! i wish people listened when it was 0.0140s!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158614587
$OZSC
$OZSC i said it in the past, and I say it again people smell fishy here. Its not even real contract, its a "potential projection of 124 millions..." the hype is over, now we re heading back to sub penny land till november
— Dave (@vietengi) September 30, 2020
8 million bid WHACKED!!
perhaps, all that LOI deal is to dump lots of shares into the hype! sad! i see the Company do file with SEC! then let's see an 8-K for this{DEAL) if legit!
0.0140 cut losses is ideal as i see it! dumping on news is very bad sign! if the LOI agreement was real, you won't see this in red!
doesn't look like peeps care anymore! amazing how they dump on such news!
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158612927
exactly what i thought! i am out
The news is out, hopefully these yesterday's whackers won't sell the news!
0.0150 to 0.0160 close doable!
OZSC Quick update - I just wrapped 2.5 hrs on Zoom with PPP in India. Terms positive. Deal is now at a value of $124 mil. They will finalize the contract in 24 hrs, with another call with both sides tomorrow at 6 am. We have 24 hrs to review and execute by Weds $OZSC
Quick update - I just wrapped 2.5 hrs on Zoom with PPP in India. Terms positive. Deal is now at a value of $124 mil. They will finalize the contract in 24 hrs, with another call with both sides tomorrow at 6 am. We have 24 hrs to review and execute by Weds $OZSC @power_conv_tech
— OZOP Energy Solutions (@OzopEnergy) September 28, 2020
0.0130 all buyers now! bid support coming
GOING BACK UP GREEN NOW! 0.02 won't be hard!
Level 2 is thinning out nicely now! buyers will be loading before eod!
looks like the flush was ended!
6 million bid!
they are done whacking now! all the best to longs!
bid whackers are gone now!
wow! 5 million whacked!!
let's see!
who's with that 5 million fake bid! is it real bid???
isn't the same old news!
$ACST 0.2199 very interesting news! could be a buy out pharma!! $1+ could be possible!
Tuesday, September 29 2020 6:55 AM, EST Acasti Announces Review Process of Strategic Alternatives GlobeNewswire "Press Releases"
LAVAL, Qubec , Sept. 29, 2020 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Acasti or the Company) (NASDAQ: ACST TSX-V: ACST) announces the Company has commenced a formal process to explore and evaluate strategic alternatives to enhance shareholder value. Towards this end, the Company has engaged Oppenheimer & Co., Inc. , as its financial advisor to assist in the process. There can be no assurance of a successful outcome from these efforts, or of the form or timing of any such outcome. The Company does not intend to make any further disclosures regarding the strategic review process unless and until a specific course of action is approved by the Companys Board of Directors.
In the meantime, the Company and its clinical advisors plan to complete the full data analyses as contemplated in the Statistical Analysis Plan for TRILOGY 2, including the secondary and exploratory endpoints, and the pooling of the data from TRILOGY 1 and 2.
Forward Looking Statements
Statements in this press release that are not statements of historical or current fact constitute forward-looking information within the meaning of Canadian securities laws and forward-looking statements within the meaning of U.S. federal securities laws (collectively, forward-looking statements). Such forward-looking statements involve known and unknown risks, uncertainties, and other unknown factors that could cause the actual results of Acasti to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. In addition to statements which explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms believes, belief, expects, intends, anticipates, potential, should, may, will, plans, continue, targetedor other similar expressionsto be uncertain and forward-looking. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Forward-looking statements in this press release include, but are not limited to, information or statements about Acastis strategy, future operations, its review of strategic options, potential value forCaPre,prospects and the plans of management.
The forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement, the Special Note Regarding Forward-Looking Statements section contained in Acastis latest annual report on Form 10-K, which will be available on EDGAR atwww.sec.gov/edgar/shtml, on SEDAR atwww.sedar.comand on the investor section of Acastis website atwww.acastipharma.com. All forward-looking statements in this press release are made as of the date of this press release. Acasti does not undertake to update any such forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. The forward-looking statements contained herein are also subject generally to assumptions and risks and uncertainties that are described from time to time in Acastis public securities filings with the Securities and Exchange Commission and the Canadian securities commissions, including Acastis latest annual report on Form 10-K under the caption Risk Factors.
Neither NASDAQ, the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange ) accepts responsibility for the adequacy or accuracy of this release.
Acasti Contact: Jan DAlvise Chief Executive Officer Tel: 450-686-4555 Email: info@acastipharma.com www.acastipharma.com
Investor Contact: Crescendo Communications, LLC Tel: 212-671-1020 Email: ACST@crescendo-ir.com
Source: Acasti Pharma, Inc.
Post 1 for 1000 split. Ex-date=02/10/2020. Pay date=02/10/2020.
already OS raised dramatically!!
As of June 30, 2020, there were 1,489,063,164 shares outstanding
As of August 10, 2020, there were 2,904,963,462 shares outstanding
As of September 01, 2020, there were 3,107,043,764 shares outstanding
Exactly if i am to bash , i would have used all the BS posting! it's only my opinion and already peeps attacking! Good luck all!
hold tight lol going to the moon ( now peeps like it)
will leave it right here.
AS and OS is so big! most lazar's shells ends up with RS! just saying!
https://www.otcmarkets.com/stock/QUTR/security
Hope it does! just saying, the EVERYTIME dump on news is so obvious and nasty!
with all respect... i don't believe that MM games story! the dumping on news been for many months!
where all shares coming from! 7 million at ask! on "NEWS" lol IF it was a retail, that would be dumb to unload on loi news @ 0.0042!!! you had your chance to dump higher!(I doubt it is)
They just whacked that 3 million bid! dump on news every time!!!
The Company has placed the initial order for electric vehicles. i thought they are an EV manufacturer!! how are they going to pay for these " placed" EV SUV?? latest financials shows they have only $112,628 in hands!!
and how did they pay for all Active Convertible Notes on 09/22/2020 PR!
not a bash, just a thought!
They keep dumping on news!
IMMB (Harry Zhabilov's other ticker) was Suspended by SEC on 11/20/2014 and it was current in filings.
Hopefully, Mr. Harry bring ENZC to current and clear the "Dark or Defunct" status as soon as possible to avoid any SEC issues!
Bring filings to current and report the LOI with BioClonetics Immunotherapeutics, Inc. by filing 8-K! A MUST!
don't you see the daily sec suspension for Defunct tickers?
overnight hold is risky for most Dark or Defunct stocks! protect your assets!